M. C. Genovese
- Rheumatology top 1%
- Hematology top 5%
- Immunology top 10%
- Genetics top 5%
- Oncology
- Co-authors
- Anthony SebbaGraeme JonesJianhui GuMatija TomšičAndrea CalvoMitchell B. LowensteinDaniel SiriThasia Woodworth
- Topics
- Rheumatoid Arthritis Research and Therapies (23 papers)Chronic Lymphocytic Leukemia Research (11 papers)Systemic Lupus Erythematosus Research (6 papers)
- Cited by
- RheumatologyHematologyGenetics
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
M. C. Genovese
35 papers receiving 809 citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Rheumatology 634
- Hematology 320
- Immunology 228
- Genetics 162
- Oncology 137
Countries citing papers authored by M. C. Genovese
This map shows the geographic impact of M. C. Genovese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. C. Genovese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. C. Genovese more than expected).
Fields of papers citing papers by M. C. Genovese
This network shows the impact of papers produced by M. C. Genovese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. C. Genovese. The network helps show where M. C. Genovese may publish in the future.
Co-authorship network of co-authors of M. C. Genovese
This figure shows the co-authorship network connecting the top 25 collaborators of M. C. Genovese. A scholar is included among the top collaborators of M. C. Genovese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. C. Genovese. M. C. Genovese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 9 | |
| 7 | 8 | |
| 8 | 2 | |
| 9 | 20 | |
| 10 | 2 | |
| 11 | 32 | |
| 12 | 12-and 24-Week Patient-Reported Outcomes From a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis | 5 |
| 13 | 24-Week Results of a Blinded Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Januse Kinase 2 Inhibitor, in Combination with Traditional Disease Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis. | 10 |
| 14 | Tofacitinib (cp-690,550), an oral Janus Kinase Inhibitor: Pooled phase 3 analysis in an Australian Rheumatoid Arthritis Study Population | 6 |
| 15 | Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis. | 8 |
| 16 | SAFETY AND TOLERABILITY OF TOCILIZUMAB IN LONG-TERM EXTENSION STUDIES OF RHEUMATOID ARTHRITIS | 1 |
| 17 | THE EFFICACY AND SAFETY OF SUBCUTANEOUS (SC) ABATACEPT (ABA) WITH OR WITHOUT MTX IN PATIENTS WITH ACTIVE RA | 2 |
| 18 | Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION studybreakdown → | 609 |
| 19 | Lack of efficacy with 3 oral dose levels of TMI-005 (Apratastat), in subjects with active rheumatoid arthritis on a background of methotrexate-A phase 2 double-blind, placebo-controlled, parallel, randomized study | 3 |
| 20 | 24 |
About M. C. Genovese
M. C. Genovese is a scholar working on Rheumatology, Genetics and Hematology, having authored 38 papers that have together received 842 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (23 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Systemic Lupus Erythematosus Research (6 papers). The work is most often cited by research in Rheumatology (634 citations), Hematology (320 citations) and Genetics (162 citations). M. C. Genovese has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Anthony Sebba, Graeme Jones, Jianhui Gu, Matija Tomšič, Andrea Calvo, Mitchell B. Lowenstein, Daniel Siri, Thasia Woodworth, Emma Alecock and Juan J. Gómez‐Reino. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.